You searched for "OIA"
Demodex blepharitis: A transatlantic comparison of treatments available in the UK and US
Demodex blepharitis is widely recognised among eyecare professionals as an important cause of chronic lid margin inflammation, dry eye and ocular surface diseases. The characteristic feature for diagnosis is the presence of waxy deposit at the lash bases on slit...Eye tests data shows only 5% of children aged five and under had an eye test in 2025
Marking World Sight Day, new analysis of UK eye tests data estimates that only around 5% of the total population of children aged 5 years and under had an eye test in 2025, despite optometrists and opticians recommending that children...The New Zealand National Eye Centre and the land of the long white cloud
Located southeast of Australia in the South Pacific Ocean, New Zealand (Aotearoa) is home to five million culturally diverse people. Renowned for its lush nature spanning from unexplored forests to active volcanos and snow-capped mountains, New Zealand has become both...What's trending Apr/May 2021
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #COVID-19prevention #spectacles Ocular transmission of COVID-19 was discussed from the very beginning of the pandemic [1-3]. Indeed, it was an Ophthalmologist,...
Mast cells in Graves’ ophthalmopathy
Graves’ ophthalmopathy (GO) is a potentially sight-threatening ocular disease, occurring in patients with hyperthyroidism due to Graves’ disease. Also known as thyroid-associated ophthalmopathy, GO is characterised by orbital infiltration by immune cells including macrophages, T cells and plasma cells, which...Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service
Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...The Lancaster Course 2026
Founded in 1946, the Lancaster Course in Ophthalmology is a unique review course hosted by Massachusetts Eye and Ear, Harvard Medical School. It has offered training to young ophthalmologists from all over the world and has supplemented training for many...The results of the last survey Feb24
Thank you to all those who participated in this edition’s survey and for those of you who attended my recent Medico-legal Seminar at the Royal College of Ophthalmologists. It was a fascinating and educational day, made a success by the...Twenty-five years in retina
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...New research shows parents confusion around their child’s eye health
Nearly one in ten parents or carers (9%) will only take their child for their first visit to the optician if and when an eye health or vision issue arises, reveals a new Children’s Eye Health Report by the Association...Advances and developments in medical retina
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...
